Sigma Investments Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Maastricht, NL Netherlands
Total Funding:N/A
Industry:Investments
Founded:1976
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Sigma Investments's estimated annual revenue is currently $11.6M per year.
  • Sigma Investments's estimated revenue per employee is $227,000

Employee Data

  • Sigma Investments has 51 Employees.
  • Sigma Investments grew their employee count by 21% last year.
  • Sigma Investments currently has 9 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Sigma Investmen...
$11.6M5121%N/AN/A
Missing a competitor? Contribute!?
Submit

Sigma Investments is the student investment club of the School of Business and Economics of Maastricht University. Sigma Investment was founded in 1976 by students of Maastricht University, it has since been Sigma's goal to bridge the gap between theoretical academia and the world of professional finance. Due to legal limitations Sigma had to change its structure in 2001. Ever since there have been two managed portfolios of about the same weight. Sigma Investments cooperates with several other associations of the School of Business and Economics, especially Scope Focus (former: FS Focus. former: Future). Because Sigma Investments has a long history, the industry ties and alumni database have improved over the years. Sigma Investment tries to bring financial markets closer to students. To achieve this objective, we hold weekly meetings in which we present industries and companies to give students the opportunity to invest their own money in one of our portfolios.

keywords:N/A

51

Number of Employees

$11.6M

Revenue (est)

9

Current Jobs

21%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Sigma Investments News

20-Mar-19 - Solar Senior Capital (SUNS) Downgraded by Zacks Investment

Zacks Investment Research cut shares of Solar Senior Capital ... Two Sigma Investments LP boosted its position in shares of Solar Senior

20-Mar-19 - Analysts Set Celldex Therapeutics, Inc. (CLDX) Price Target at $31.44

Zacks Investment Research raised Celldex Therapeutics from a “hold” ... Finally, Two Sigma Investments LP increased its position in Celldex